DGX vs ORC · P/E 22, rev $5.94B vs P/E 7.0, rev $322.0M
Quest Diagnostics Incorporated (DGX) versus Orchid Island Capital Inc. (ORC) — a side-by-side from cached financials, not a winner call.
Quest Diagnostics Incorporated (DGX) is a diagnostics & research company listed on US.
Orchid Island Capital Inc. (ORC) is a reit - mortgage company listed on NYSE.
Latest reported DGX revenue for 2026-06-30 was $5.94B. Net income was $572.0M. DGX currently screens at market cap $19.94B and trailing P/E 22.4.
Latest reported ORC revenue for 2026-06-30 was $322.0M. Net income was $69.2M. ORC currently screens at market cap $1.33B and trailing P/E 7.0.
DGX currently screens at market cap $19.94B and trailing P/E 22.4. ORC currently screens at market cap $1.33B and trailing P/E 7.0.
Not investment advice. Open the DGX and ORC stock pages for the full models.
Not investment advice.